Long-term follow-up of theMAINTAINNephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term follow-up of theMAINTAINNephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 75, Issue 3, Pages 526-531
Publisher
BMJ
Online
2015-03-11
DOI
10.1136/annrheumdis-2014-206897
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biologic Therapy in Lupus Nephritis
- (2015) Frédéric A. Houssiau NEPHRON CLINICAL PRACTICE
- Ten Common Mistakes in the Management of Lupus Nephritis
- (2013) Bhadran Bose et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis
- (2013) Jose R. Maneiro et al. RHEUMATOLOGY
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials
- (2012) Lorna K. Henderson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis--Should MMF Be Considered the Drug of Choice?
- (2012) B. H. Rovin et al. Clinical Journal of the American Society of Nephrology
- Mycophenolate mofetilversusazathioprine as maintenance therapy for lupus nephritis: A meta-analysis
- (2012) Li Feng et al. NEPHROLOGY
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients
- (2012) Frédéric A Houssiau ARTHRITIS RESEARCH & THERAPY
- Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial
- (2011) M. S. Stoenoiu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- (2011) Mary Anne Dooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
- (2010) F. A. Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
- (2009) M. Mosca et al. ANNALS OF THE RHEUMATIC DISEASES
- The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
- (2009) F A Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Prednisone, Lupus Activity, and Permanent Organ Damage
- (2009) M. THAMER et al. JOURNAL OF RHEUMATOLOGY
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started